Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Update on Mystery Illness

By HospiMedica staff writers
Posted on 03 Apr 2003
A team of scientists in the department of microbiology, University of Hong Kong, has successfully cultured the viral agent that causes severe acute respiratory syndrome (SARS) and has made progress in developing a reliable diagnostic test.

The basic test relies on the technique of neutralizing antibodies. More...
In experiments to determine the test's accuracy, scientists found it was able to detect tell-tale antibodies in sera taken from eight SARS patients. This early test will now be further developed into a more sophisticated diagnostic test. "This spectacular achievement is an example of what the world can do when the intellectual resources of nations around the world are focused on a single problem,” said Klaus Stohr, a virologist with the World Health Organization (WHO, Geneva, Switzerland), who is coordinating the global laboratory network.

Canadian researchers have released findings suggesting that the metapneumovirus, which belongs to the paramyxoviridae family, may be the cause of SARS. However, mounting evidence points to a member of the coronavirus family, according to WHO scientists. WHO has established a network of doctors and laboratories who have had experience with SARS. They are using e-mail and teleconferencing to exchange and compare information as quickly as possible.

A new wave of SARS cases has been reported in Vietnam and Singapore, according to WHO. However, following the initial reports of explosive outbursts of the illness among healthcare workers and the rapid spread of the illness, barrier precautions appear to have greatly reduced further spread among healthcare workers in many countries. Barrier precautions include the wearing of gowns, gloves, masks, and goggles. WHO guidelines state that after their discharge, SARS patients should be carefully monitored for a week. Also, WHO is asking airports in cities affected to query international passengers about their health and to discourage travel in those having experienced a fever in the prior 24 hours.




Related Links:
WHO

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
12-Channel ECG
CM1200B
New
Vessel Sealing Instrument
ERGOseal
New
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elyra TFL System uses thulium fiber laser technology for efficient stone dusting and reduced stone migration, with an air-cooled design for quieter, more compact operation (photo courtesy of BD

BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.